STAT+: ‘A Lego kit for health care builders’: Jonathan Bush launches Zus with medical records in mind
Jonathan Bush is back for another act. On Thursday, the founder and former chief executive…
Author: STAT
.jpg)
Opinion: A surprising pandemic side effect: People are more engaged with their health
About a month ago, one of our patients, a man in his mid-40s, came to…
STAT+: Planned changes at Soros’ Open Society has access-to-medicines advocacy groups on edge
The Open Society Foundations, one of the world’s largest backers of public health initiatives, is…
STAT+: American Medical Association delegates vote to support controversial Covid-19 IP waiver
The American Medical Association delegates voted at their annual meeting to support a controversial proposal…
STAT+: Pharmalittle: Regeneron Covid-19 drug cuts risk of death in some patients; bills reintroduced to help develop new antibiotics
Good morning, folks. And how are you today? We are in fine spirits, thanks to…
Opinion: Listen: Two Alzheimer’s experts with opposing viewpoints on Aduhelm
This week’s “First Opinion Podcast” is a special two-part episode focusing on the controversial —…
STAT+: Lawmakers revive legislation to accelerate the development of new antibiotics
After months of anticipation, a bipartisan group of U.S. lawmakers is reintroducing bills in the…
Q&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision
Harry Johns is ready to stop talking about whether or not the Food and Drug…
.jpg)
Sewage sleuths helped an Arizona town beat back Covid-19. For wastewater epidemiology, that’s just the start
GUADALUPE, Ariz. — Valerie Molina anxiously searched the desert sky, scanning the horizon for any…
Regeneron antibody saves lives in some hospitalized Covid patients, study finds
A monoclonal antibody treatment for Covid-19 developed by Regeneron saved lives among hospitalized patients who…
STAT+: ‘A litany of flaws’: Advocacy group urges HHS to boot FDA officials over Alzheimer’s drug approval
Reacting to the controversial approval of the Biogen (BIIB) Alzheimer’s drug, a leading advocacy group…
STAT+: Former FDA chief Hahn defends his jump to Flagship Pioneering, the firm behind Moderna
When biotech investor Flagship Pioneering announced that it had hired former Food and Drug Administration…
STAT+: Amazon has made its Covid-19 test available online, alongside a diagnostics portal for consumers
Amazon has made its FDA-cleared Covid-19 test available to consumers online, alongside a consumer diagnostics…
Opinion: 6 ways the FDA’s approval of Aduhelm does more harm than good
Like many people, I was shocked when the Food and Drug Administration ignored the advice…
STAT+: Centene to pay $143 million to two states to settle allegations of overcharging Medicaid
Centene (CNC), a major health insurer, agreed to pay a combined $143 million to Ohio…
STAT+: Biden administration moves to axe Trump 340B rule targeting community clinics
WASHINGTON — The Biden administration on Tuesday moved to axe a Trump-era policy that would…
STAT+: STAT+ Conversations: How Covid changed health misinformation online
Editors note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: AstraZeneca antibody therapy failed to prevent Covid-19; former FDA Commish Hahn joins Moderna backer
Hello, everyone, and how are you today? We are doing just fine, thank you, courtesy…
STAT+: Sage antidepressant achieves goals of large study, but questions about benefit linger
Sage Therapeutics said Tuesday that an experimental pill designed to alleviate depression with a two-week…
Opinion: The approval of aducanumab isn’t the end of the story. It’s just the beginning
People living with Alzheimer’s dementia — the forgetfulness, the confusion, and the ultimate erasure of…
Opinion: A resilience prescription for Covid-19 and other traumatic events
One morning almost five years ago, a disgruntled former employee tried to kill me with…
STAT+: Scientists CRISPR patients’ own immune cells in bid to shrink hard-to-treat GI tumors
Last year, researchers at the University of Pennsylvania, led by immunotherapy pioneer Carl June, showed…
STAT+: Buying the data: Health care lobbyists fund their own policy analyses, clouding Washington debates
WASHINGTON — Sen. Chuck Grassley’s voice boomed through the Senate hearing room — it sounded…
Why two scientific powerhouses are teaming up to tackle rare cancers long overlooked in research
As a medical school student, oncologist Vinod Ravi felt like he understood what it took…
Extra Covid vaccine may help protect transplant patients
A small study offers the first hint that an extra dose of Covid-19 vaccines just…
STAT+: Mississippi becomes the first state to jointly sue drug makers and PBMs over the cost of insulin
In a first-of-its-kind move, the Mississippi attorney general last week filed a lawsuit accusing several…
STAT+: Pharmalittle: Novavax says Covid-19 shot is highly effective; doctors scramble to advise patients on Alzheimer’s drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: GSK pays up big for rights to TIGIT-targeted cancer immunotherapy from Iteos
Iteos Therapeutics said Monday that it has sold ownership rights to an experimental anti-TIGIT cancer…
Novavax Covid-19 vaccine highly effective in late-stage trial, long-awaited results show
Novavax’s Covid-19 vaccine was highly effective in preventing symptomatic infections, hospitalizations, and severe illnesses, long-awaited…
Opinion: America’s broken PPE supply chain must be fixed now
Almost everyone knows by now that the U.S. was ill-prepared to combat Covid-19. But few…
Opinion: Are five decades of progress in women’s health in peril?
Reviewing 50 years of progress on medical issues relevant to women can be a daunting…
‘I’m just winging it’: Faced with confusing data on the new Alzheimer’s drug, doctors scramble to advise their patients
Their phones are ringing off the hook and their email inboxes are filling up with…
STAT+: The unlikely force shaping Amazon’s health plans: A veteran, doctor, and TV persona with big ideas for tech
If you know the name Vin Gupta, chances are it’s because he tends to spar…
Children in rural areas face increasing barriers to pediatric care, study finds
Hospital beds for children with asthma, pneumonia, viral infections, and other serious illnesses have declined…
STAT+: ‘Simply unacceptable’: Alzheimer’s Association blasts Biogen over the price of its new medicine
In harsh tones, the Alzheimer’s Association sharply criticized Biogen (BIIB) for the $56,000 price tag…
Opinion: If vaccine apartheid exists, vaccine billionaires shouldn’t
To understand why billionaires are a sign of moral and economic failure, look no further…
To explore space radiation’s impact on reproduction, scientists sent freeze-dried mouse sperm to the ISS
While billionaires like Jeff Bezos and Elon Musk were vying to launch themselves into space,…
STAT+: Pharmalittle: A third FDA panel member resigns over Alzheimer’s drug approval; agency’s decision hardens opposition to Woodcock
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Unaffordable treatment for severe malaria highlights U.S. drug market pitfalls
When Eli Lilly announced in 2017 that it would stop producing quinidine, it was the…
STAT+: Advocates blast the FDA for not moving as fast on ALS as on Alzheimer’s
WASHINGTON — The Food and Drug Administration fast-tracked Biogen’s divisive Alzheimer’s drug Aduhelm, but it’s…
STAT+: A CRISPR treatment for blood diseases shows curative promise in small study
Twenty-two patients with inherited blood disorders were free of severe pain and the need for…
FDA accuses company of distributing unapproved Covid test and using falsified data
The Food and Drug Administration announced a recall Thursday of a coronavirus rapid antigen test,…
FDA accuses company of distributing unapproved Covid test and using falsified data
The Food and Drug Administration announced a recall Thursday of a coronavirus rapid antigen test,…
Third member of FDA expert committee resigns over controversial Alzheimer’s therapy decision
A third member of a Food and Drug Administration expert panel has resigned over the…
Listen: Every angle on the FDA’s polarizing approval of Biogen’s Alzheimer’s drug
Was the FDA right to approve Aduhelm? What’s a fair price for a debatable drug?…
STAT+: Vertex shelves second drug for inherited lung disease, raising concerns about future growth
Vertex Pharmaceuticals said Thursday that an experimental protein “corrector” drug — the highest-priority medicine in…
U.S. health officials report higher-than-expected heart inflammation cases following Covid-19 vaccination
Federal health officials said Thursday they’re seeing rare but higher-than-expected cases of a heart issue…
STAT+: What’s next for the new Alzheimer’s drug? Lots of thorny issues ahead
Despite all the excitement surrounding the FDA’s approval on Monday of a controversial treatment for Alzheimer’s disease, the…
STAT+: In potential big step forward for CAR-T, Bristol Myers says its therapy outperformed stem cell transplant in blood cancer
The treatment known as CAR-T, in which white blood cells are genetically modified to attack…
NIH releases a plan to confront structural racism. Critics say it’s not enough
Saying structural racism is a chronic problem throughout biomedical research and within their own walls,…